1. Home
  2. ALT vs EFT Comparison

ALT vs EFT Comparison

Compare ALT & EFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • EFT
  • Stock Information
  • Founded
  • ALT 1997
  • EFT 2004
  • Country
  • ALT United States
  • EFT United States
  • Employees
  • ALT N/A
  • EFT N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • EFT Finance Companies
  • Sector
  • ALT Health Care
  • EFT Finance
  • Exchange
  • ALT Nasdaq
  • EFT Nasdaq
  • Market Cap
  • ALT 292.0M
  • EFT 327.7M
  • IPO Year
  • ALT N/A
  • EFT N/A
  • Fundamental
  • Price
  • ALT $3.83
  • EFT $12.08
  • Analyst Decision
  • ALT Strong Buy
  • EFT
  • Analyst Count
  • ALT 6
  • EFT 0
  • Target Price
  • ALT $17.40
  • EFT N/A
  • AVG Volume (30 Days)
  • ALT 3.0M
  • EFT 100.8K
  • Earning Date
  • ALT 08-12-2025
  • EFT 01-01-0001
  • Dividend Yield
  • ALT N/A
  • EFT 10.63%
  • EPS Growth
  • ALT N/A
  • EFT N/A
  • EPS
  • ALT N/A
  • EFT 1.73
  • Revenue
  • ALT $20,000.00
  • EFT N/A
  • Revenue This Year
  • ALT N/A
  • EFT N/A
  • Revenue Next Year
  • ALT $761,880.20
  • EFT N/A
  • P/E Ratio
  • ALT N/A
  • EFT $7.62
  • Revenue Growth
  • ALT N/A
  • EFT N/A
  • 52 Week Low
  • ALT $2.90
  • EFT $11.10
  • 52 Week High
  • ALT $11.16
  • EFT $13.44
  • Technical
  • Relative Strength Index (RSI)
  • ALT 51.79
  • EFT 43.69
  • Support Level
  • ALT $3.35
  • EFT $12.00
  • Resistance Level
  • ALT $3.66
  • EFT $12.24
  • Average True Range (ATR)
  • ALT 0.19
  • EFT 0.08
  • MACD
  • ALT 0.07
  • EFT 0.01
  • Stochastic Oscillator
  • ALT 86.18
  • EFT 63.16

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About EFT Eaton Vance Floating Rate Income Trust of Beneficial Interest

Eaton Vance Floating-rate Income Trust is a closed-end management investment company. The company's objective is to provide a high level of current income and its secondary objective is capital appreciation.

Share on Social Networks: